Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers review the similarities and differences between OARSI and ESCEO 2019 guidelines for the management of knee OA and provide a narrative to help steer health-care providers through the complexities of non-surgical management of the disease.

A doctor treats a patient with knee osteoarthritis © Shutterstock

The burden of knee osteoarthritis is set to continue to increase around the world. Ageing populations and rising levels of obesity, combined with an absence of a cure for the disease, will lead to an increased strain on health-care systems. Due to this, there is a focus on how to best manage the disease.  

Clinical management is difficult and recommended treatment strategies routinely include a combination of non-pharmacological, pharmacological and in some cases surgical interventions. Management can further be categorised by disease severity, joint site and the presence/absence of comorbidities making OA treatment increasingly personalised.

Facing such complexities, health-care providers turn to clinical practice guidelines to help inform the decision-making process. But according to a research team from the Universities of Oxford, Southampton, Liège, Oulu, Maryland, Oslo and Boston, the complexities for clinicians don’t end there.

“Leading experts and national and international organisations frequently publish guidelines outlining the best strategies for managing osteoarthritis,” said Thomas Perry, joint first author and Postdoctoral Research Fellow in Sport, Exercise and Osteoarthritis at NDORMS, University of Oxford. “There are a number of OA organisations across the world, each publishing new updated algorithms for how to best manage osteoarthritis, which means it can be difficult for clinicians to keep track of the most up-to-date literature, best practice policies, and ultimately provide the best care for their patients.”

In 2019, when OARSI (Osteoarthritis Research Society International) and ESCEO (European Society for Clinical and Economic Aspects of Osteoporosis) updated their guidelines for the non-surgical management of knee osteoarthritis, Nigel Arden, Professor of Rheumatic Diseases at NDORMS proposed a review of their new algorithms. Together with members from OARSI and ESCEO, a working group examined the similarities and differences between the two guidelines and created a narrative to help guide health-care providers through the complexities of treatments.

The results are published today in Nature Reviews Rheumatology.  

Simplified list of OARSI and ESCEO treatments for the non-surgical treatment of knee OA from the 2019 guidelines. Image - Nature Reviews Rheumatology Simplified list of OARSI and ESCEO treatments for the non-surgical treatment of knee OA from the 2019 guidelines. Image - Nature Reviews Rheumatology

The guidelines are similar in the majority of their recommendations. OARSI and ESCEO both recommend education, structured exercise and weight loss as core treatments for knee OA and advise the use of topical NSAIDs as first-line treatments, and oral NSAIDs and intra-articular injections for persistent pain. Where they differed was in ESCEO’s recommendation for the use of low-dose, short-term acetaminophen, pharmaceutical grade glucosamine and chondroitin sulfate, as compared to OARSI which strongly recommends against their use (including all glucosamine and chondroitin formulations).

Thomas said: “It’s reassuring that the majority of recommendations from OARSI and ESCEO are in agreement. The working group concluded that the most likely reason for the differences were down to the methodologies of how they each approach the data and the literature. Each organisation uses slightly different procedures which could translate into the few, but important differences observed. It also highlights that there remain contested treatments for which we need better quality data to confirm use or non-use in the management of knee OA. Moving forward, there is also a need to define a standard protocol, outlining a method for making treatment algorithms which can be adopted by all societies.” 

Summary of the voting procedures for the OARSI and ESCEO working groups. Image - Nature Reviews Rheumatology Summary of the voting procedures for the OARSI and ESCEO working groups. Image - Nature Reviews Rheumatology

Professor Arden said: “It was the first time that OARSI and ESCEO had come together to discuss their guidelines and it proved a very positive experience. Our aspiration would be to expand the collaboration to other societies and to harmonise the algorithms in order to present a consistent set of recommendations, providing confidence and clarity for practising clinicians regarding the treatment for their patients.”

Similar stories

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Womens Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.